These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 22926232)
1. Severe propylene glycol toxicity secondary to use of anti-epileptics. Pillai U; Hothi JC; Bhat ZY Am J Ther; 2014; 21(4):e106-9. PubMed ID: 22926232 [TBL] [Abstract][Full Text] [Related]
2. Recognition, treatment, and prevention of propylene glycol toxicity. Zar T; Graeber C; Perazella MA Semin Dial; 2007; 20(3):217-9. PubMed ID: 17555487 [TBL] [Abstract][Full Text] [Related]
3. Propylene glycol-induced lactic acidosis in a patient with normal renal function: a proposed mechanism and monitoring recommendations. Neale BW; Mesler EL; Young M; Rebuck JA; Weise WJ Ann Pharmacother; 2005 Oct; 39(10):1732-6. PubMed ID: 16159998 [TBL] [Abstract][Full Text] [Related]
4. Propylene glycol-induced lactic acidosis in a patient receiving continuous infusion pentobarbital. Miller MA; Forni A; Yogaratnam D Ann Pharmacother; 2008 Oct; 42(10):1502-6. PubMed ID: 18698010 [TBL] [Abstract][Full Text] [Related]
7. Removal of propylene glycol and correction of increased osmolar gap by hemodialysis in a patient on high dose lorazepam infusion therapy. Parker MG; Fraser GL; Watson DM; Riker RR Intensive Care Med; 2002 Jan; 28(1):81-4. PubMed ID: 11819005 [TBL] [Abstract][Full Text] [Related]
8. Propylene glycol toxicity: a severe iatrogenic illness in ICU patients receiving IV benzodiazepines: a case series and prospective, observational pilot study. Wilson KC; Reardon C; Theodore AC; Farber HW Chest; 2005 Sep; 128(3):1674-81. PubMed ID: 16162774 [TBL] [Abstract][Full Text] [Related]
9. Determination of a lorazepam dose threshold for using the osmol gap to monitor for propylene glycol toxicity. Yahwak JA; Riker RR; Fraser GL; Subak-Sharpe S Pharmacotherapy; 2008 Aug; 28(8):984-91. PubMed ID: 18657015 [TBL] [Abstract][Full Text] [Related]
10. Relationship of continuous infusion lorazepam to serum propylene glycol concentration in critically ill adults. Arroliga AC; Shehab N; McCarthy K; Gonzales JP Crit Care Med; 2004 Aug; 32(8):1709-14. PubMed ID: 15286548 [TBL] [Abstract][Full Text] [Related]
11. Osmol gap as a surrogate marker for serum propylene glycol concentrations in patients receiving lorazepam for sedation. Barnes BJ; Gerst C; Smith JR; Terrell AR; Mullins ME Pharmacotherapy; 2006 Jan; 26(1):23-33. PubMed ID: 16422667 [TBL] [Abstract][Full Text] [Related]
12. Propylene glycol accumulation in critically ill patients receiving continuous intravenous lorazepam infusions. Horinek EL; Kiser TH; Fish DN; MacLaren R Ann Pharmacother; 2009 Dec; 43(12):1964-71. PubMed ID: 19920159 [TBL] [Abstract][Full Text] [Related]
13. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. Treiman DM; Meyers PD; Walton NY; Collins JF; Colling C; Rowan AJ; Handforth A; Faught E; Calabrese VP; Uthman BM; Ramsay RE; Mamdani MB N Engl J Med; 1998 Sep; 339(12):792-8. PubMed ID: 9738086 [TBL] [Abstract][Full Text] [Related]